Le Lézard
Classified in: Health
Subjects: PDT, VET, PET

Canine Companions® Launches the CanineAlerttm Device


The device supports earlier intervention for veterans experiencing symptoms of PTSD.

SANTA ROSA, Calif., April 8, 2024 /PRNewswire/ -- Canine Companions®, the nonprofit organization that transforms the lives of children, adults, and veterans with disabilities, by providing them with expertly trained service dogs free of charge, announces the launch of the groundbreaking CanineAlerttm Device. For many veterans, PTSD-induced nightmares are a debilitating aspect of daily life impacting sleep quality, overall well-being and daily functioning. Canine Companions® expertly trained service dogs already support veterans experiencing PTSD but the addition of this device alerts the service dogs earlier and enables them to interrupt PTSD episodes earlier, leading to a shorter recovery period process. The CanineAlerttm Device integrates state-of-the-art technology with the specialized training of Canine Companions® service dogs, offering a more comprehensive solution to the traumatic nightmares experienced by veterans living with the symptoms of PTSD.

The CanineAlerttm Device, developed and patented by Canine Companions® in-house team, monitors the wearer's heart rate and wirelessly communicates with a collar device worn by the service dog. The collar activates a specific vibration that prompts the service dog into action. Unlike conventional approaches that focus only on interrupting nightmares, the CanineAlerttm Device also facilitates a faster recovery process by training the service dogs to initiate tasks aimed at reducing anxiety and hypervigilance in veteran's post-nightmare.

"Our CanineAlerttm Device is a significant advancement in mitigating the impacts of PTSD," says Paige Mazzoni, CEO of Canine Companions®. "By combining innovative technology with the abilities of our trained service dogs, Canine Companions® is able to provide veterans a better and faster solution for managing their symptoms. The CanineAlerttm Device is a revolutionary approach to managing PTSD and will improve the lives of many veterans. We are excited to broaden the application of the patent and technology over time, to help clients with a wider variety of symptoms and disabilities."

Canine Companions® developed the CanineAlerttm Device to improve upon one of the most popular skills among Canine Companions® service dogs, the ability to recognize active nightmares and intervene by pulling off blankets or otherwise waking their humans and interrupting the episode. Statistics gathered from current Canine Companions®' veteran clients reflect how much the dogs already do to support veterans suffering from PTSD: 

About Canine Companions®
As the leader of the service dog industry, Canine Companions® provides service dogs to adults, children and veterans with disabilities and facility dogs to professionals working in healthcare, criminal justice and educational settings at no cost to clients. This powerful relationship leads to increased independence, self-esteem and inclusion for a person with a disability. Established in 1975, Canine Companions® is a nonprofit 501(c)3 with six regions across the country serving all 50 states. Learn more at canine.org or call 1-800-572-BARK.

Media Contact:
Jeanine Konopelski
707-577-1759
[email protected]

SOURCE Canine Companions®


These press releases may also interest you

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 07:00
Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on TERLIVAZ® (terlipressin) for injection in patients with hepatorenal syndrome (HRS) with rapid reduction in kidney function1 at the 2024...

17 mai 2024
Family Braces, Calgary's largest group of orthodontists with five locations across the city, reports a strong start to the second quarter of 2024. This positive momentum builds on the group's successful first quarter, underlining its...

17 mai 2024
American Skin Association (ASA) announced the recipients of the 2024 Inaugural Founders Award and the 2024 Research Achievement Awards at the 2024 Society for Investigative Dermatology (SID) Annual Meeting. ...



News published on and distributed by: